Acute lymphoblastic leukemia in an infant exposed to zidovudine in utero and early infancy

AIDS

Volumn 14, Issue 15, 2000, Pages 2410-2411

  Moschovi, M ^a   Theodoridou, M ^a   Papaevangelou, V ^a   Tzortzatou Stathopoulou, F ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD EXAMINATION; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEVER; HEPATOSPLENOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANCY; INFANT; LEUKEMIA REMISSION; LYMPHADENOPATHY; LYMPHOCYTE COUNT; MALE; POLYMERASE CHAIN REACTION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROPHYLAXIS; VIRUS LOAD; ACUTE LYMPHOCYTIC LEUKEMIA; CHEMICALLY INDUCED DISORDER; DISEASE TRANSMISSION; FEMALE; LETTER; PREGNANCY; PRENATAL EXPOSURE;

DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; ZIDOVUDINE;

EID: 0033626437     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200010200-00028     Document Type: Article

References (4)

1. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
2. A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease
3. Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine
4. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women